GleamWall
中文EN

IMCR Immunocore Holdings plc

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 1671927 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY13.1%
TTM net income YoY-9.9%
TTM EPS YoY-10.3%
Revenue 3-yr CAGR25.9%
Net income 3-yr CAGR—

Margins

Gross margin98.9%
Operating margin-6.8%
Net margin-7.5%
FCF margin-4.2%
EBITDA margin-5.9%

Returns

ROE-7.9%
ROA-2.9%
ROIC (approx.)—
Asset turnover0.38x

Leverage & solvency

Liabilities / assets62.8%
Debt / equity0.00x
Current ratio4.62x
Interest coverage-2.37x

Cash quality & payout

Operating cash flow / net income0.32x
Accruals ratio-1.9%
Payout ratio—
Capex / revenue1.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$400.02M$310.20M
Cost of revenue$5.09M$2.73M
Gross profit$394.93M$307.47M
R&D expense$274.87M$222.15M
SG&A expense$165.41M$155.78M
Operating income-$45.35M-$70.46M
Interest expense$12.17M$18.84M
Pretax income-$19.10M-$52.94M
Income tax$16.41M-$1.85M
Net income-$35.51M-$51.09M
EBITDA-$42.25M-$66.26M
EPS (basic)-0.71-1.02
EPS (diluted)-0.71-1.02
Dividends declared per share0.000.00
Weighted avg. shares (diluted)50.35M49.99M
Balance sheet
Cash & equivalents$467.71M$455.73M
Short-term investments$396.44M$364.64M
Receivables—$63.01M
Inventory$6.74M$5.45M
Current assets$996.74M$929.86M
PP&E, net$11.46M$10.09M
Total assets$1.07B$1.01B
Current liabilities$246.70M$212.18M
Total liabilities$686.24M$648.79M
Shareholders' equity$381.03M$360.72M
Shares outstanding50.69M50.06M
Cash flow statement
Operating cash flow-$10.71M$26.06M
Capital expenditure$4.34M$5.17M
Free cash flow-$15.05M$20.89M
Investing cash flow-$16.34M-$355.13M
Financing cash flow$12.37M$343.88M
Depreciation & amortization$3.10M$4.20M
Stock-based compensation$37.70M$34.19M

Free plan shows the latest 2 periods; Pro shows all 8 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.